Works by Tang, Ling‐Long


Results: 81
    1
    2

    Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma: The DIPPER Randomized Clinical Trial.

    Published in:
    JAMA: Journal of the American Medical Association, 2025, v. 333, n. 18, p. 1589, doi. 10.1001/jama.2025.1132
    By:
    • Liang, Ye-Lin;
    • Liu, Xu;
    • Shen, Liang-Fang;
    • Hu, Guang-Yuan;
    • Zou, Guo-Rong;
    • Zhang, Ning;
    • Chen, Chuan-Ben;
    • Chen, Xiao-Zhong;
    • Zhu, Xiao-Dong;
    • Yuan, Ya-Wei;
    • Yang, Kun-Yu;
    • Jin, Feng;
    • Hu, Wei-Han;
    • Xie, Fang-Yun;
    • Huang, Ying;
    • Han, Fei;
    • Tang, Ling-Long;
    • Mao, Yan-Ping;
    • Lu, Li-Xia;
    • Sun, Rui
    Publication type:
    Article
    3

    Tissue-resident microbiota signature in nasopharyngeal carcinoma.

    Published in:
    Microbiome, 2025, v. 13, n. 1, p. 1, doi. 10.1186/s40168-025-02114-w
    By:
    • Tan, Xi-Rong;
    • Qiao, Han;
    • Li, Ying-Qing;
    • Jiang, Wei;
    • Huang, Sheng-Yan;
    • Gong, Sha;
    • Li, Wen-Fei;
    • Tang, Ling-Long;
    • Zhou, Guan-Qun;
    • Liang, Ye-Lin;
    • Li, Hui;
    • He, Qing-Mei;
    • Bai, Jie-Wen;
    • Ye, Ming-Liang;
    • Wang, Jing-Yun;
    • Huang, Sai-Wei;
    • Li, Jun-Yan;
    • Gan, Chun-Qiao;
    • Li, Ying-Qin;
    • Zhao, Yin
    Publication type:
    Article
    4

    Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial.

    Published in:
    CA: A Cancer Journal for Clinicians, 2025, v. 75, n. 3, p. 203, doi. 10.3322/caac.21881
    By:
    • Tang, Ling‐Long;
    • Chen, Lin;
    • Xu, Gui‐Qiong;
    • Zhang, Ning;
    • Huang, Cheng‐Long;
    • Li, Wen‐Fei;
    • Mao, Yan‐Ping;
    • Zhou, Guan‐Qun;
    • Lei, Feng;
    • Chen, Lu‐Si;
    • Huang, Shao Hui;
    • Chen, Lei;
    • Chen, Yu‐Pei;
    • Zhang, Yuan;
    • Liu, Xu;
    • Xu, Cheng;
    • Zhao, Yin;
    • Li, Ji‐Bin;
    • Liu, Na;
    • Xie, Fang‐Yun
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 12, p. 2230, doi. 10.1002/cncr.28049
    By:
    • Chen, Yong;
    • Sun, Ying;
    • Liang, Shao‐Bo;
    • Zong, Jing‐Feng;
    • Li, Wen‐Fei;
    • Chen, Mo;
    • Chen, Lei;
    • Mao, Yan‐Ping;
    • Tang, Ling‐Long;
    • Guo, Ying;
    • Lin, Ai‐Hua;
    • Liu, Meng‐Zhong;
    • Ma, Jun
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    42
    44
    45
    46

    The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.

    Published in:
    Cancer Communications, 2021, v. 41, n. 11, p. 1195, doi. 10.1002/cac2.12218
    By:
    • Tang, Ling‐Long;
    • Chen, Yu‐Pei;
    • Chen, Chuan‐Ben;
    • Chen, Ming‐Yuan;
    • Chen, Nian‐Yong;
    • Chen, Xiao‐Zhong;
    • Du, Xiao‐Jing;
    • Fang, Wen‐Feng;
    • Feng, Mei;
    • Gao, Jin;
    • Han, Fei;
    • He, Xia;
    • Hu, Chao‐Su;
    • Hu, De‐sheng;
    • Hu, Guang‐Yuan;
    • Jiang, Hao;
    • Jiang, Wei;
    • Jin, Feng;
    • Lang, Jin‐Yi;
    • Li, Jin‐Gao
    Publication type:
    Article
    47
    48
    49
    50